This grant opportunity, offered by a clinical research funding department, is designed to significantly improve the adoption of digital therapeutics for Substance Use Disorders (SUD) by payors. Its primary aim is to fund rigorous clinical trials that generate compelling, data-driven evidence. This evidence is essential for demonstrating the efficacy, cost-effectiveness, and overall value of existing and developing SUD digital therapeutics to insurance providers and other payors. This grant is for the specific purpose of accelerating the integration of these innovative digital health solutions into standard healthcare practices, ultimately ensuring broader access for individuals battling SUD by overcoming current adoption barriers.
Opportunity ID: 341593
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-23-018 |
| Funding Opportunity Title: | Enabling SUD Digital Therapeutics Research to Improve Payor Adoption (R44- Clinical Trial Only) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jun 29, 2022 |
| Last Updated Date: | Jun 29, 2022 |
| Original Closing Date for Applications: | Nov 15, 2022 |
| Current Closing Date for Applications: | Nov 15, 2022 |
| Archive Date: | Dec 21, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $2,500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | To ensure that digital therapeutics that have been or are in the development for SUD are adopted, this funding opportunity concept aims to fund clinical trials that will generate convincing data to improve adoption by the payors. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-018.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 341593 Full Announcement-RFA-DA-23-018 -> RFA-DA-23-018-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00275359 | Oct 15, 2022 | Nov 15, 2022 | View |
Package 1
Mandatory forms
341593 RR_SF424_5_0-5.0.pdf
341593 PHS398_CoverPageSupplement_5_0-5.0.pdf
341593 RR_OtherProjectInfo_1_4-1.4.pdf
341593 PerformanceSite_4_0-4.0.pdf
341593 RR_KeyPersonExpanded_4_0-4.0.pdf
341593 RR_Budget_3_0-3.0.pdf
341593 PHS398_ResearchPlan_4_0-4.0.pdf
341593 SBIR_STTR_Information_3_0-3.0.pdf
341593 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
341593 RR_SubawardBudget30_3_0-3.0.pdf
341593 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
